These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21109972)

  • 1. Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activation.
    Zhang H; Ozaki I; Hamajima H; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Yamamoto K; Mizuta T
    Oncol Rep; 2011 Jan; 25(1):159-66. PubMed ID: 21109972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.
    Xia J; Matsuhashi S; Hamajima H; Iwane S; Takahashi H; Eguchi Y; Mizuta T; Fujimoto K; Kuroda S; Ozaki I
    J Nutr Biochem; 2012 Dec; 23(12):1668-75. PubMed ID: 22475810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of NF-kappaB in hepatocellular carcinoma cell.
    Wang J; Huang Q; Chen M
    Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
    Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells.
    Moon DO; Kim MO; Lee JD; Kim GY
    Cancer Lett; 2008 Jun; 264(2):192-200. PubMed ID: 18314260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K2-derived compounds induce growth inhibition in radioresistant cancer cells.
    Amalia H; Sasaki R; Suzuki Y; Demizu Y; Bito T; Nishimura H; Okamoto Y; Yoshida K; Miyawaki D; Kawabe T; Mizushina Y; Sugimura K
    Kobe J Med Sci; 2010 Sep; 56(2):E38-49. PubMed ID: 21063145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
    Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
    Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
    Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB.
    Li J; Minnich DJ; Camp ER; Brank A; Mackay SL; Hochwald SN
    J Surg Res; 2006 May; 132(1):112-20. PubMed ID: 16337965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells.
    Wang Q; Huang S; Yang L; Zhao L; Yin Y; Liu Z; Chen Z; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2008 Sep; 40(9):819-29. PubMed ID: 18776995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
    Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
    Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
    Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
    Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
    Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
    Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC
    Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
    Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K
    Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.